MannKind Corporation (MNKD): Price and Financial Metrics

MNKD POWR Grades

• MNKD scores best on the Growth dimension, with a Growth rank ahead of 96.65% of US stocks.
• The strongest trend for MNKD is in Value, which has been heading up over the past 177 days.
• MNKD ranks lowest in Stability; there it ranks in the 10th percentile.

MNKD Stock Summary

• MANNKIND CORP's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 6.05% of US listed stocks.
• MNKD's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 5.64% of US stocks.
• As for revenue growth, note that MNKD's revenue has grown 140.99% over the past 12 months; that beats the revenue growth of 95.96% of US companies in our set.
• Stocks that are quantitatively similar to MNKD, based on their financial statements, market capitalization, and price volatility, are VAPO, APPS, OTRK, BYND, and SONX.
• MNKD's SEC filings can be seen here. And to visit MANNKIND CORP's official web site, go to www.mannkindcorp.com.

MNKD Valuation Summary

• MNKD's price/sales ratio is 6.9; this is 263.16% higher than that of the median Healthcare stock.
• MNKD's price/sales ratio has moved NA NA over the prior 233 months.

Below are key valuation metrics over time for MNKD.

MNKD Growth Metrics

Its 2 year net income to common stockholders growth rate is now at -102.86%.
• Its 3 year cash and equivalents growth rate is now at 91.81%.
• Its year over year price growth rate is now at -23.63%.

Over the past 33 months, MNKD's revenue has gone up $13,188,000.

The table below shows MNKD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	76.226	-90.65	-97.514
2022-06-30	65.612	-77.761	-87.508
2022-03-31	69.998	-67.226	-94.008
2021-12-31	75.442	-61.709	-80.926
2021-09-30	81.37	-49.127	-79.276
2021-06-30	74.511	-47.403	-86.105

MNKD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• MNKD has a Quality Grade of C, ranking ahead of 42.97% of graded US stocks.
• MNKD's asset turnover comes in at 0.384 -- ranking 124th of 680 Pharmaceutical Products stocks.
• VERU, PLX, and LGND are the stocks whose asset turnover ratios are most correlated with MNKD.

The table below shows MNKD's key quality metrics over time.